CTBO
Cantabio Pharmaceuticals Inc
Price:
0
USD
Volume:
United States | Professional, Scientific, and Technical Services
CTBO Gross Margin
As of 2025-07-13, the Gross Margin of Cantabio Pharmaceuticals Inc (CTBO) is 7775.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
CTBO Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2018-03-31 | 7775.2% |
| 2017-03-31 | - |
| 2016-03-31 | - |
| 2015-03-31 | - |
| 2014-03-31 | - |
| 2013-03-31 | - |
| 2012-03-31 | - |
| - | |
| - | |
| - |
CTBO Gross Margin - Peers Comparison